Stay updated on SPR1NT Clinical Trial
Sign up to get notified when there's something new on the SPR1NT Clinical Trial page.

Latest updates to the SPR1NT Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedCore content updated from a specific disease subtype to a broader category and version bumped to v3.2.0; a government operating-status notice was added.SummaryDifference3%
- Check15 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%
- Check36 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, specifically St. Louis, Missouri, and the introduction of Zolgensma, a treatment for proximal spinal muscular atrophy. However, many related terms and previous location details have been removed.SummaryDifference2%
- Check58 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to SPR1NT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPR1NT Clinical Trial page.